Structural immunotherapy: Harnessing chemical design to build powerful next-generation therapeutics
Open Access
- 3 November 2025
- journal article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (45)
Abstract
Structural immunotherapy relies on the structural features of immunotherapeutics in addition to component identity to influence biodistribution, intra- or extracellular localization, target engagement, and processing kinetics. This strategy is poised to redefine how immunotherapeutics mobilize immunity against disease and transform our ability to harness structure–function relationships to enhance clinical outcomes.Keywords
Funding Information
- HHS | NIH | National Cancer Institute (R01CA275430 R01CA257926 R01CA208783)
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (U54DK137516)
This publication has 171 references indexed in Scilit:
- Substituting Poly(ethylene glycol) Lipids with Poly(2‐ethyl‐2‐oxazoline) Lipids Improves Lipid Nanoparticle Repeat DosingAdvanced Healthcare Materials, 2024
- Delivery Route Considerations for Designing Antigen‐Specific Biomaterial Strategies to Combat AutoimmunityAdvanced NanoBiomed Research, 2023
- Biomaterial Strategies for Selective Immune Tolerance: Advances and GapsAdvanced Science, 2023
- Injectable Nanoparticle‐Based Hydrogels Enable the Safe and Effective Deployment of Immunostimulatory CD40 Agonist AntibodiesAdvanced Science, 2022
- Enhancing anti‐PD‐1 Immunotherapy by Nanomicelles Self‐Assembled from Multivalent Aptamer Drug ConjugatesAngewandte Chemie International Edition, 2021
- Delivery of Stimulator of Interferon Genes (STING) Agonist Using Polypeptide‐Modified Dendrimer Nanoparticles in the Treatment of MelanomaAdvanced NanoBiomed Research, 2021
- Nanoparticles containing constrained phospholipids deliver mRNA to liver immune cells in vivo without targeting ligandsBioengineering & Translational Medicine, 2020
- Nanoparticle‐Conjugate TLR7/8 Agonist Localized Immunotherapy Provokes Safe Antitumoral ResponsesAdvanced Materials, 2018
- Enhancing the Stability and Immunomodulatory Activity of Liposomal Spherical Nucleic Acids through Lipid‐Tail DNA ModificationsSmall, 2017
- A Powerful CD8+ T‐Cell Stimulating D‐Tetra‐Peptide Hydrogel as a Very Promising Vaccine AdjuvantAdvanced Materials, 2016